NEW YORK (GenomeWeb News) – Cell-analysis tool company Fluxion Biosciences said today that it has expanded its sales and service network into Asia through a pair of distribution agreements and an instrument sale.

Fluxion, based in South San Francisco, Calif., said that it signed a distribution agreement for its BioFlux instrument line with Korea's DI Biotech, and a second agreement with Novel Science to sell both the BioFlux and IonFlux platforms in Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.